P357. Role of THD in patients affected by Crohn's disease and haemorrhoidal disease: a preliminary study
G. Giarratano1, A. Stazi1, C. Toscana2, L. Franceschilli3, A. Gaspari3, P. Sileri3, 1Clinica Madonna delle Grazie, Surgery, Velletri, Italy, 2Clinica Villa Tiberia, Surgery, Rome, Italy, 3University of Rome Tor Vergata, Department of Sperimental medicine and Surgery, Rome, Italy
This prospective study was designed to analyze outcomes of transanal haemorrhoidal dearterialization (THD) for the treatment of haemorrhoidal disease in patients affected by Crohn's disease (CD).
During 2012 ten patients (5F, 5M, mean age 28) affected by CD and third or fourth degree haemorrhoids were enrolled to the study. Preoperatively, all underwent clinical examination and proctoscopy. Patients were evaluated with respect to the operative time, pain scores, complications, return to work, level of satisfaction and recurrency.
Clinical data were obtained at the end of the 5th postoperative day and at 1, 3 and 12 months following surgery.
The median follow up period was 18 months. Minor complication included: urinary retention (n = 1), mild (<6 month) urgency (n = 2), postoperative bleeding (n = 2). No major complication. No late complication. No recurrency.
THD is a safe and effective day-care procedures for the treatment of grade III and grade IV haemorrhoids in patients affected by CD. Return to work is quick and patient satisfaction is high with a low rate of recurrency.